Call to arrange a consultation
+1 416 777 0888
Search the site
ViiV Healthcare Company et al. v. JAMP Pharma Corporation
2024
T-938-24
Pending
6(1) PMNOC
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,606,282, 2,967,453, and 3,003,988 (dolutegravir-abacavir-lamivudine).
Counsel to:
JAMP Pharma Corporation
The decision is reported
here.
Meet the team
